دورية أكاديمية

European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis: A European Renal Best Practice (ERBP) endorsement of ISTH Guidelines for Treatment of Thrombotic Thrombocytopaenic Purpura (TTP) with some refinements for Europe

التفاصيل البيبلوغرافية
العنوان: European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis: A European Renal Best Practice (ERBP) endorsement of ISTH Guidelines for Treatment of Thrombotic Thrombocytopaenic Purpura (TTP) with some refinements for Europe
المؤلفون: Eller, Kathrin, Knoebl, Paul, Bakkaloglu, Sevcan A, Menne, Jan J, Brinkkoetter, Paul T, Grandt, Leonie, Thiem, Ursula, Coppo, Paul, Scully, Marie, Haller, Maria C
المصدر: Nephrology Dialysis Transplantation; Jul2022, Vol. 37 Issue 7, p1229-1234, 6p
مصطلحات موضوعية: THROMBOTIC thrombocytopenic purpura, HEMOSTASIS, BEST practices, SCHOENLEIN-Henoch purpura, THROMBOSIS, VON Hippel-Lindau disease
مصطلحات جغرافية: EUROPE
مستخلص: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease that is caused by severe ADAMTS-13 deficiency. Immune-mediated TTP develops due to autoantibodies against ADAMTS-13, whereas congenital TTP is caused by mutations in the ADAMTS13 gene. Diagnostic possibilities and treatment options in TTP have emerged in recent years, which prompted the International Society on Thrombosis and Haemostasis (ISTH) to publish clinical practice guidelines for the diagnosis and treatment of TTP in 2020. In this article, the European Renal Best Practice Working Group endorsed the ISTH guidelines and emphasizes a number of considerations, including the importance of rapid ADAMTS-13 activity testing, the use of rituximab and anti-von Willebrand factor therapies such as caplacizumab, that enhance the clinical applicability of the guidelines in Europe. [ABSTRACT FROM AUTHOR]
Copyright of Nephrology Dialysis Transplantation is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09310509
DOI:10.1093/ndt/gfac034